X
CAD
$1000,395,000
CannTrust
BOUGHT DEAL, JUNE 2018
Mergers & Acquisition Advisory
Enabling strategic transactions
The mergers and acquisitions advisory capability at Bloom Burton guides clients to conceptualize, structure and execute transactions to maximize returns and company performance.
Our team’s professional expertise in healthcare and intellectual property also allows us to guide our clients with scientific and technical due diligence on their M&A opportunities and development strategies.
Guiding a broad range of M&A-type transactions
- Strategic Acquisitions
- Sales & Divestitures
- Spinoffs & Splitoffs
- Strategic Partnerships
- Reorganization & Restructuring
- Leveraged Buyouts
- Takeover Defenses and Proxy Contests
- Special Committee Assignments
- Fairness/Valuation Opinions
For more information on our M&A services, please contact:
Jolyon Burton
jburton@bloomburton.com
416-640-7585
RECENT ISSUES AND FINANCING
X
CDN$56,000,000
adMare BioInnovations
MERGER & ACQUISTION ADVISORY
MARCH 2020
adMare BioInnovations
X
US$178,000,000
Dahlin Pharma
MERGER & ACQUISTION ADVISORY
DECEMBER 2019
Acquisition of Seroquel XR by Dahlin Pharma and Cheplapharm.
Bloom Burton Securities Inc. acted as advisor to Dahlin Pharma.
Dahlin Pharma
X
US$110,000,000
Nuvo Pharmaceuticals Inc.
MERGER & ACQUISTION ADVISORY
DECEMBER 2018
Nuvo Pharmaceuticals Inc.
X
UP TO CDN$88,000,000
Pediapharm Inc.
Merger & Acquisition Advisory
OCTOBER 2018
Pediapharm Inc.
X
Precision Nutrition
MERGER & ACQUISTION ADVISORY
DECEMBER 2017
Precision Nutrition
X
EUR €13,900,000
Hamilton Thorne Ltd.
MERGER & ACQUISTION ADVISORY
APRIL 2017
Hamilton Thorne Ltd.
X
US $10,250,000
LED Medical Diagnostics Inc.
MERGER & ACQUISITION ADVISORY
FEBRUARY 2017
LED Medical Diagnostics Inc.
X
CAD $6,000,000
Red Leaf Medical Inc.
MERGER & ACQUISITION ADVISORY
SEPTEMBER 2016
Red Leaf Medical Inc.
X
Response Biomedical Corp.
MERGER & ACQUISITION ADVISORY
AUGUST 2016
Response Biomedical Corp.
X
Noden Pharma Inc.
MERGER & ACQUISITION ADVISORY
JULY 2016
Noden Pharma Inc.
X
US $148,000,000
Tribute Pharmaceuticals Canada Inc.
Merger & Acquisition Advisory
FEBRUARY 2016
Tribute Pharmaceuticals Canada Inc.
X
Canadian Public Biotech Company
MERGER & ACQUISITION ADVISORY
JANUARY 2016
Canadian Public Biotech Company
X
CAD $47,000,000
Alveda Pharmaceuticals Inc.
Merger & Acquisition Advisory
NOVEMBER 2015
Alveda Pharmaceuticals Inc.
X
CAD $25,000,000
Medical Futures Inc.
Merger & Acquisition Advisory
JUNE 2015
Medical Futures Inc.
X
US $73,200,000
CRH Medical Corporation
Merger & Acquisition Advisory
DECEMBER 2014
CRH Medical Corporation
X
US $45,000,000
Nuvo Research Inc.
Merger & Acquisition Advisory
OCTOBER 2014
Nuvo Research Inc.
X
Warnex Inc.
MERGER & ACQUISITION ADVISORY
MAY 2014
Warnex Inc.
X
Bioniche Life Sciences Inc.
MERGER & ACQUISITION ADVISORY
MARCH 2014
Bioniche Life Sciences Inc.
X
CAD $7,530,000
Triton Pharma Inc.
Mergers & Acquisition Advisory
JANUARY 2014
Triton Pharma Inc.
X
Approx. CAD $357,000,000
Medicago Inc.
MERGER & ACQUISITION ADVISORY
SEPTEMBER 2013
Medicago Inc.
X
Approx. CAD $13,000,000
Thallion Pharmaceuticals Inc.
MERGER & ACQUISITION ADVISORY
August 2013
Thallion Pharmaceuticals Inc.
X
Victhom Human Bionics Inc.
MERGER & ACQUISITION ADVISORY
MARCH 2013
Victhom Human Bionics Inc.
X
Approx. US 510,000,000
YM BioSciences Inc.
MERGER & ACQUISITION ADVISORY
DECEMBER 2012
YM BioSciences Inc.
X
Warnex Inc.
MERGER & ACQUISITION ADVISORY
OCTOBER 2012
Warnex Inc.
X
Pharmagap Inc.
MERGER & ACQUISITION ADVISORY
JULY 2012
Pharmagap Inc.
X
Approx. CAD $10,000,000
Stellar Pharmaceuticals Inc.
MERGER & ACQUISITION ADVISORY
DECEMBER 2011
Stellar Pharmaceuticals Inc.
X
Advitech Inc.
MERGER & ACQUISITION ADVISORY
OCTOBER 2011
Advitech Inc.
X
Miraculins Inc.
MERGER & ACQUISITION ADVISORY
AUGUST 2010
Miraculins Inc.
X
Patient Home Monitoring Corp.
MERGER & ACQUISITION ADVISORY
JUNE 2010
Patient Home Monitoring Corp.
X
Approx. CAD $7,000,000
DiaMedica Inc.
MERGER & ACQUISITION ADVISORY
JUNE 2010
DiaMedica Inc.
X
Conjuchem LLC
MERGER & ACQUISITION ADVISORY
MARCH 2010
Conjuchem LLC
X
Approx. CAD $12,500,000
YM Biosciences Inc.
MERGER & ACQUISITION ADVISORY
FEBRUARY 2010
YM Biosciences Inc.
X
Medicure Inc.
MERGER & ACQUISITION ADVISORY
JANUARY 2010
Medicure Inc.
X
Bradmer Pharmaceuticals Inc.
MERGER & ACQUISITION ADVISORY
JULY 2009
Bradmer Pharmaceuticals Inc.
X
Med BioGene Inc.
MERGER & ACQUISITION ADVISORY
June 2009
Med BioGene Inc.
